Researchers Identify Successful Strategies for Weight Loss in the Obese
Findings published in the American Journal of Preventive Medicine
San Diego, CA, April 10, 2012 – A third of Americans are now obese, and up to 70% of them are trying to lose weight. In a new study published in the American Journal of Preventive Medicine, researchers from Harvard Medical School and Beth Israel Deaconess Medical Center in Boston have found in a nationally representative sample that obese dieters who said they ate less fat, exercised more, and used prescription weight loss medications were more likely to lose weight. Diet foods and products, nonprescription diet pills, and popular diets were less successful, according to the researchers.
“Despite popular perception that obese people are unable to lose weight, a substantial number of obese participants in our study did report successful weight loss, suggesting that some obese U.S. adults can and do lose weight,” says lead investigator Jacinda M. Nicklas, MD, MPH, MA, Clinical Research Fellow, Beth Israel Deaconess Medical Center and Harvard Medical School.
Investigators analyzed data from the 2001-2006 National Health and Nutritional Examination Survey, which collects demographic, health, and health behavior information from non-institutionalized U.S. adults. From the sample of over 4000 obese adults with a self-reported body mass index (BMI) of 30 or higher who participated in the in-home survey, they found that 63% of the respondents tried to lose weight in the last year.
Survey participants were more likely to report a weight loss of at least 5% of body weight if they reported eating less fat, exercising more, and using prescription weight loss medications. Those who lost at least 10% were also more likely to have joined a weight loss program. “Although national guidelines recommend a loss of 10% of body weight for improved health in the obese, studies have found that even a modest weight loss of 5% can lead to health benefits,” says Dr. Nicklas.
Liquid diets, nonprescription diet pills, and popular diets showed no association with successful weight loss, and those who reported losing more than 10% body weight were less likely to report eating diet foods and products, compared to those who lost less. “Interestingly, although participants engaging in formal weight loss programs may be required to consume certain diet products or foods, in our study, adults who said they used diet products were actually associated with being less likely to achieve at least 10% weight loss,” notes Dr. Nicklas. “This suggests that the structure of being in a program may be more important. It is possible that some dieters may be overeating diet products because they believe they are healthy, or low in calories.”
In the study, prescription weight loss medications were associated with successful weight loss but were used by a small number of participants. “These results tell us that Americans use many weight loss strategies that are not associated with significant weight loss, including nonprescription weight loss medications. Public health efforts directing Americans to adopt more proven methods may be warranted,” concludes Dr. Nicklas.
# # #
Notes for editors
“Successful Weight Loss Among Obese U.S. Adults,” by J.M. Nicklas, K.W. Huskey, R.B. Davis, and C.C. Wee (DOI: 10.1016/j.amepre.2012.01.005). It appears in the American Journal of Preventive Medicine, Volume 42, Issue 5 (May 2012), published by Elsevier.
Full text of the article is available to credentialed journalists upon request; contact Beverly Lytton at +1 858 534 9340 oreAJPM@ucsd.edu. Journalists wishing to interview the study authors may contact Kelly Lawman at +1 617 667 7305 or firstname.lastname@example.org.
About the American Journal of Preventive Medicine
The American Journal of Preventive Medicine ( www.ajpm-online.net) is the official journal of The American College of Preventive Medicine ( www.acpm.org) and the Association for Prevention Teaching and Research ( www.aptrmweb.org). It publishes articles in the areas of prevention research, teaching, practice and policy. Original research is published on interventions aimed at the prevention of chronic and acute disease and the promotion of individual and community health. The journal features papers that address the primary and secondary prevention of important clinical, behavioral and public health issues such as injury and violence, infectious disease, women's health, smoking, sedentary behaviors and physical activity, nutrition, diabetes, obesity, and alcohol and drug abuse. Papers also address educational initiatives aimed at improving the ability of health professionals to provide effective clinical prevention and public health services. The journal also publishes official policy statements from the two co-sponsoring organizations, health services research pertinent to prevention and public health, review articles, media reviews, and editorials.
The American Journal of Preventive Medicine, with an Impact Factor of 4.110, is ranked 10th out of 140 Public, Environmental and Occupational Health titles and 18th out of 151 General & Internal Medicine titles according to the 2010 Journal Citation Reports® published by Thomson Reuters.About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
+ 1 858 534 9340